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SUMMARY
Traditionally the enteric pathogen Yersinia enterocolitica has been differentiated into biogroups.
Despite being considered as non-pathogenic, biogroup 1A isolates have constituted a sizeable
fraction of strains from patients with gastroenteritis in many reports. To establish a potential
clinical significance for biogroup 1A isolates of Y. enterocolitica, clinical disease in patients
with gastroenteritis excreting such isolates was compared with symptoms among patients found
infected with pathogenic biogroups. Clinical data and isolates of 66 patients from whom Y.
enterocolitica had been isolated by direct plating were available for study. There was an
association between patient age below 3 years and infection with 'pathogenic' Y. enterocolitica.
The severity of gastroenteritis and other symptoms, however, did not depend on the biogroup,
or the presence of the virulence plasmid in the yersinia strain isolated from the patients. Strains
belonging to biogroup 1A of Y. enterocolitica showed two clusters of ribotypes, one of which
encompassed most isolates recovered from humans, the other being associated with
environmental isolates. This might indicate the existence of human-adapted and potentially
pathogenic strains among biogroup 1A of Y. enterocolitica.
INTRODUCTION
Yersinia enterocolitica has been described as an agent
of bacterial gastroenteritis worldwide (reviewed in
[1]). Its prevalence varies widely between geographic
regions, and in colder climates Y. enterocolitica may
rival salmonellae as cause of infectious gastroenteritis
[2]. Strains of Y. enterocolitica are traditionally
differentiated into biogroups, of which biogroups IB,
2, 3, 4 and 5 have been designated as pathogenic,
whereas the biogroup 1A is considered to be non-
pathogenic [3]. Strains of the former biogroups 3A
and 3B have recently been reassigned to new species of
the genus, i.e. Y. mollaretii and Y. bercovieri [4].
Among the pathogenic strains of Y. enterocolitica,
biogroups 2 and 4 are frequently recovered from
humans in Europe, whereas biogroup IB is most
prevalent in the USA. The remaining pathogenic
biogroups are considered primarily animal pathogens,
although strains of biogroup 3 are found occasionally
in humans [5]. The pathogenic mechanisms involved
in infections by yersiniae have been widely studied at
a molecular level. Strains of Y. enterocolitica belong-
ing to pathogenic biogroups have been shown to
possess an array of virulence-associated genetic
elements. In particular, all pathogenic strains have a
44-47 Md virulence plasmid [3], as well as chromo-
somal virulence genes, such as the enterotoxin gene
yst [6] and the invasion-associated gene ail [7]. There
is no doubt about the clinical significance of infections
with pathogenic Y. enterocolitica and therefore a
simple biogrouping scheme is considered part of the
standard laboratory workup for this organism in
reference textbooks [8]. However, the role of non-
pathogenic strains in human disease has been more
controversial [9].
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In Switzerland, the annual incidence of human Y.
enterocolitica infections is estimated to be 1-4 per
100000, based on notifications to the Federal Office of
Public Health, and compared to 82 per 100000 for
Salmonella spp. [10]. Among the human isolates of Y.
enterocolitica sent to the Swiss National Reference
Laboratory for confirmation and typing, about 60 %
of the strains had been of the non-pathogenic
biogroup 1A in previous years. In order to study the
clinical significance of Y. enterocolitica belonging to
biogroup 1A and to obtain an unbiased estimate of
the occurrence of such isolates, all strains isolated in
two clinical microbiology laboratories from humans
during the study period were analysed. Because we
hypothesized that clinical symptoms might differ
between patients infected with pathogenic and non-
pathogenic yersiniae, medical histories of these patient
groups were compared. A special effort was made to
obtain information on potential late sequelae of
yersinia infection. Some patients with disease due to
Y. enterocolitica develop symptoms of arthritis and
erythema nodosum as late complications [1]. The
possibility of an association between pathogenicity of
the infecting strain and the development of these
complications had not been addressed before.
M E T H O D S
Bacterial strains, culture conditions and laboratory
procedures
During the study period, January 1992 to June 1994,
all isolates identified as Yersinia enterocolitica in two
clinical microbiology laboratories were analysed. The
laboratory of Dr O. Lutz, Winterthur, Switzerland
contributed 16 strains, and the laboratory of Dr
Viollier, Basel, Switzerland another 19 strains. An
additional 36 sporadic isolates of yersinia referred on
a voluntary basis to the Swiss National Reference
Laboratory for Foodborne Diseases for confirmation
and typing by another 16 clinical microbiology
laboratories were also analysed. All laboratories used
commercially available formulations of the CIN
Yersinia selective agar [11] for culture of yersinae, at
temperatures between 22 °C and 30 °C for 48 h,
depending on the standard procedures of the labora-
tories. No enrichment cultures for yersiniae were
performed. Other enteric pathogens were isolated by
each laboratory with their usual procedures, and the
presence of other pathogens besides yersinia was
recorded. Four reference strains from the collection of
H. H. Mollaret, Institut Pasteur, Paris, were used for
comparison: IP 134, biogroup 4, serogroup 03, IP
383, biogroup 2, serogroup O9, IP 1105, biogroup IB,
serogroup O8, and IP 885, the reference strain for
serogroup O5, 27.
For culturing, strains were never incubated at
temperatures above 30 °C to minimize loss of the
virulence plasmid. The strains of yersinia were
identified to species and biogroup level in standard
media [12], using the following biochemical reactions
at 30 °C: decarboxylation of lysine and ornithine,
production of urease, deamination of phenylalanine,
hydrolysis of Tween 80 [13], pyrazinamide [14],
ONPG, and aesculin, fermentation of glucose, man-
nitol, lactose, saccharose, rhamnose, dulcitol, raffi-
nose, cellobiose, melibiose, inositol, sorbitol, xylose,
and mucate, utilisation of malonate, citrate and
acetate, production of gas, acetoin, indole, and H2S,
and the methyl-red reaction. Motility was tested at
30 °C and 37 °C, and congo-red binding as well as
low-calcium-response were determined on congo-red
magnesium oxalate agar [15]. Slide agglutinations
with rabbit sera against serogroups O3, O9, O5, and
O8 of Y. enterocolitica were performed with com-
mercially available reagents (catalogue no. 311103 to
311106, Denka Seiken, Japan).
Patient characteristics and clinical data
Stool cultures for yersinia had been performed in the
laboratories at the request of the patients' physicians.
All medical histories were reviewed with the physician
by telephone interview by one investigator (A. F.), and
the data were coded in Epi Info for analysis [16].
Information was sought on clinical signs including
diarrhoea, abdominal cramps, symptoms of appen-
dicitis (right lower quadrant pain, leucocytosis, and
guarding), gross blood in stools, fever, septicaemia,
requirement for antibiotic treatment, duration of
antimicrobial treatment, duration of symptoms, and
hospitalization. The medical history was also checked
for illnesses predisposing to yersiniosis or late compli-
cations [1], especially diabetes, haemochromatosis,
liver cirrhosis, iron overload, and HLA B27 histo-
compatibility antigen, or general medical conditions
associated with decreased host defences, like cancer
and HIV infection. A follow-up call at least 3 weeks
after the acute episode was made to ascertain the
presence of late complications, i.e. arthritis and
erythema nodosum [1]. Food histories were, not
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recorded but foreign travel was recorded as a potential
factor influencing the risk of infection with Y.
enterocolitica biogroups.
Molecular biology techniques
Genomic DNA was extracted by a modified guani-
dium thiocyanate microprocedure [17]. Nucleases
were inactivated by extraction with a mixture of
phenol-chloroform-isoamyl alcohol (25:24:1) in-
stead of chloroform alone [18]. For the colony-blot,
representative colonies of each strain of Y. entero-
colitica were inoculated onto filters marked with a
grid (Millipore HAWG 047 S3, Millipore Corporation
Bedford, MA 01730) overlying Luria-Bertani agar
plates [18], and incubated at 30 °C overnight. Colonies
were lysed and DNA fixed to the filters essentially as
already described [19], by placing the filters on filter
paper (Whatman 3 MM) soaked with 0-5 M-NaOH
and 1-5 M-NaCl for 30 min, then 1 M-Tris-HCl pH 75,
l-5M-NaCl for 10 min, afterwards with buffer A
(50 mM-Tris-HCl pH 80, 125 mM-NaCl, 10 mM-
EDTA, and 05 % SDS) for 10 min, finally with buffer
A containing 5 mg/ml lysozyme for 10 min. After 2 h
of fixation at 80 °C in a vacuum oven and 1 h of
treatment with buffer A containing 02 mg/ml pro-
teinase K at 50 °C, the filters were washed in a buffer
containing 50 mM-Tris-HCl pH 7-6 and 1 M-NaCl,
1 mM-EDTA, and 01 % SDS for 1 h at 50 °C.
Non-radioactively labelled probes for hybridization
were prepared as follows. For the a;7-probe, plasmid
pVM103 [20] was cut with the restriction enzymes
Clal and Aval according to the manufacturers
instruction (Boehringer Mannheim, Rotkreuz, Switzer-
land), and the fragments were separated by agarose
gel electrophoresis. The 1-3 kb Clal-Aval fragment
was extracted from the gel [18], and labelled with
DIG-dUTP by random priming following the instruc-
tions of the manufacturer (Boehringer). Digoxigenin
labelled probes targeting the Y. enterocolitica yst-gene
and 16S ribosomal RNA sequences were prepared by
PCR. To a standard 100/d PCR mixture, containing
2-5 U of Taq DNA polymerase (Boehringer), 170 fiu
of dNTP, and 025 juM of oligonucleotide primers in
lOmM-Tris pH 8-3, 15mM-MgCl2, 50 mM-KCl, and
0005% each of Tween 20 and NP-40, DIG-dUTP
(cat no. 1093088, Boehringer) was added in a
concentration of 50 /IM. For the >>.y?-probe, genomic
DNA of a reference isolate of Y. enterocolitica O3
biogroup 4 (638-93) was used as template, purified
pKK3535 plasmid DNA, containing the complete E.
coli rrnB operon [21] served as template for the rrn-
probes. The sequences of the oligonucleotide primers
were 5-AAT GCT GTC TTC ATT TGG-3' and 5'-
CGG GAT TGC AAC ATA CAT-3' for the yst-
probe [6], and 5-ATT GAA GAG TTT GAT CAT
GGC TCA-3' and 5-CTC CCA TGG TGT GAC
GGG CGG TGT GTA-3' for the 16S and 5-CTT
AGA AGC AGC CAT CAT TT-3' and 5-CTT TTA
TCC GTT GAG CGA TG-3' for the 23S rrn-probes,
respectively. Amplification was performed in a DNA
thermal cycler (Perkin-Elmer Cetus) and was taken
through 35 cycles with 1 min each at the following
temperatures: denaturation at 94 °C, annealing at
50 °C for the ys t-probe, 48 °C for the 16S rrw-probe,
and 56 °C for the 23S rrn-probe, and elongation at
74 °C.
For ribotyping, the DNA was cut with the
restriction enzymes Pvull which had been shown to be
most discriminatory on preliminary analysis, accord-
ing to the instructions of the manufacturer (Boeh-
ringer). DNA was transferred to nylon membranes
(Boehringer) by alkaline transfer with 0-4 M-NaOH in
a 2016 VacuGene vacuum blotting device (LKB,
Bromma, Sweden). Hybridization and detection were
performed both for colony blots as well as Southern
blots following the instructions of the manufacturer
(DNA labelling and detection kit non-radioactive,
Boehringer). The stringency wash after hybridization
was carried out twice in 0-2 x SSC (30 mM-NaCl,
3 mM-trisodium citrate pH 70) with 0 1 % SDS for
15 min at 68 °C.
RESULTS
During the study period, 81 isolates of presumptive
Yersinia enterocolitica were analysed. Among these,
10 strains belonged to other, recently described species
of Yersinia; five were identified as Y. bercovieri, two
each as Y. kristensenii and Y. intermedia, and one was
Y. frederiksenii. Of the 71 isolates identified as Y.
enterocolitica, 26 belonged to the non-pathogenic
biogroup 1A, 22 to biogroup 2, 20 to biogroup 4, and
3 to biogroup 3. Table 1 summarizes the ability of
different methods to discriminate reliably between
pathogenic biogroups of Y. enterocolitica and the
non-pathogenic biogroup 1A. Several biochemical
tests were useful for discrimination and gave com-
parable results. Prototrophy was also found a very
useful discriminating character. Yersinia enterocolitica
belonging to pathogenic biogroups uniformly failed to
utilize sodium acetate in a mineral base medium,
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Pyrazinamidase
Aesculin hydrolysis on
aesculin agar
Acetate utilization
Agglutinationt
Hybridization with ail
Hybridization with yst
Tiny red colonies on
CR-Mox agar
bile
probe
probe
100
100
100
96
100
100
100
Table 1. Sensitivity and specificity of various
laboratory tests to detect pathogenic Y.
enterocolitica compared to full biogrouping*
Sensitivity Specificity
Test (%) (%)
100
100
96
73
96
100
100
* There were 45 isolates of pathogenic biogroups, and 26
isolates of nonpathogenic biogroup 1A.
t Agglutination in O3, O9, O5, and O8 antisera.
whereas all but one isolate of biogroup 1A were
positive in this test. Slide agglutinations with rabbit
sera against the predominant pathogenic serotypes
were less satisfactory. However, elimination of the
results of agglutination in the O5 antiserum increased
the specificity of this test to 100 %, with only 2 % loss
in sensitivity.
Except for one strain of biogroup 1A reacting with
the a//-probe, genetic methods and full biogrouping
gave identical results. In addition, all pathogenic
isolates were carrying the virulence plasmid, as
measured by calcium dependence and congo-red
binding (Table 1). This was important for our study,
because it was ascertained that the patient isolates
either contained the full set of virulence attributes
defined so far, or lacked them completely, rendering
the comparison more meaningful.
The clinical signs and symptoms of patients infected
with Y. enterocolitica of biogroup 1A were compared
with those of patients in whom Y. enterocolitica of
pathogenic biogroups had been isolated. Data for two
patients infected with biogroup 1A isolates, an 89-
year-old female and an 88-year-old male, were not
available because either the patient file or the doctor
could not be located. Four isolates belonging to the
pathogenic biogroup 2 were isolated in three children
and their mother during a family outbreak, probably
due to faecal contamination of the drinking water
source in their private well by runoff from a manured
meadow. Only the index case, a 4-year-old girl, was
included in the analysis. Thus, with the other 3 family
cases excluded, and data missing for 2 cases, there
were 66 of the original 71 patients available for study.
Table 2. Clinical signs and findings in 66 patients
infected with pathogenic or non-pathogenic isolates of
Y. enterocolitica
Percent prevalence among
patients infected with
Y. enterocolitica belonging to
Finding
Diarrhoea
Abdominal cramps
Vomiting
Blood in stool
Fever above 38 °C
Pseudoappendicitis
Treatment with antibiotic
Hospitalization
Septicaemia
Duration > 2 weeks
Age below 3 years
Predisposing medical
conditionst
Other enteric pathogens
found X
Foreign travel
Arthritis§
Erythema nodosum§
Non-pathogenic
biogroup 1A
(n = 23*)
91
23
9
0
27
9
48
14
0
33
4
9
13
24
0
0
Pathogenic
biogroups
(n = 43*)
88
33
16
9
29
9
57
10
2
45
33||
7
5
17
0
0
* Number of patients in group.
t Antineoplastic drugs (2), aortic aneurysm (1), diabetes
mellitus (1), IgG2 deficiency (1).
J Salmonella (2), giardia (2), rotavirus (1).
§ Late complications ascertained by follow-up telephone
call.
|| Chi square 6-79, P <00\.
The results are presented in Table 2. No significant
differences were found, except for the fact that
pathogenic Y. enterocolitica predominated in children
below the age of 3 years. The mean age for the
patients infected with biogroup 1A isolates of Y.
enterocolitica was 28 ( + 23) years, in contrast to 24
(+ 24) years for patients infected with pathogenic Y.
enterocolitica.
Several measures of disease severity (fever, need for
antibiotics or hospitalization, occurrence of pseudo-
appendicitis) did not differ between the groups. The
occurrence of blood in stools was observed only in
patients infected with pathogenic biogroups of Y.
enterocolitica; however this was a rare symptom. No
late complications (arthritis or erythema nodosum)
could be ascertained by follow-up telephone call. One
patient with a mycotic aneurysm of the aorta infected
with Y. enterocolitica of biogroup 4 and septicaemia
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(A)
9 10 Std.
(B)
zymes, including Narl, Sad, BssHll, EcoRV, BamHl,
Clal, Ncol, Bell, and Kpnl had shown Pvull to give
the most discriminatory profiles. The results for
representative isolates are shown in Fig. 1. All isolates
of biogroup 4 showed the same ribopattern, which
was identical to the profiles of biogroup 3 strains. All
strains belonging to biogroup 2 also had a conserved
pattern. Bands of 4-4, 80 and > 10 kb were shared
between strains of biogroups 2, 3 and 4. In contrast,
strains of biogroup 1A had more varied patterns, even
if two groups of profiles could be clearly recognized.
All but one of the patient isolates of biogroup 1A
belonged to the first group of profiles, represented by
strains 1139-93, 896-3, and 132-93 in Fig. 1. An
environmental isolate included for comparison in the
rightmost lane of Fig. 1 belonged to a second group of
profiles, predominant in the environment, and isolated
from only one patient in the study.
1 2 3 4 5 6 7 8 9 10 Std.
Fig. 1. Pvull ribosomal RNA profiles of representative
isolates of Yersinia enterocolitica biogroups. Panel A:
profiles generated with the 16S ribosomal RNA probe.
Panel B: profiles generated with the 23S ribosomal RNA
probe. Lanes 1-3: human isolates belonging to pathogenic
biogroup 4 (546-93, 1100-93, 638-93), lane 4: human
isolate of pathogenic biogroup 2 (5865-92), lane 5: human
isolate of pathogenic biogroup 3 (1775-92), lanes 6-8:
representatives of common ribotypes among human bio-
group 1A isolates (1139-93,896-93,132-93), lane 9: ribotype
of the only human isolate of biogroup 1A resembling
environmental strains (1322-93), lane 10: representative
environmental isolate of biogroup 1A from lake water [33].
Std: molecular weight standard, digoxigenin-labelled
lambda DNA restricted with HindlW.
died. Because of the differences in age distribution
observed between the groups, and because age had
been shown to influence clinical presentation of
yersiniosis in previous studies, the data were also
subjected to a stratified analysis. Neither the strati-
fication of data by age, nor the exclusion of data from
patients concomitantly infected with other enteric
pathogens modified the observed lack of association
between yersinia biogroups and symptoms in any
way. Symptoms of pseudoappendicitis were not
observed in children, and the youngest patient with
this complication was 17 years of age. Ribotyping
with Pvull and 16S as well as 23S ribosomal RNA
probes was performed for all the Y. enterocolitica
strains included in the study in order to assess their
epidemiology. Preliminary testing with different en-
DISCUSSION
The study was prompted by the observation in
previous years that many strains of Y. enterocolitica
isolated from faeces of patients with gastroenteritis
had belonged to the biogroup 1A, traditionally
regarded as being nonpathogenic. Almost 40% of
human Y. enterocolitica strains received during the
study period were of the biogroup 1A. The sample
may have been somewhat biased, but non-pathogenic
isolates are by no means rare, and the frequency of
their occurrence observed here is consistent with
reports by other investigators [9,22,23]. Three ap-
proaches could be considered to measure the potential
clinical significance of biogroup 1A isolates of Y.
enterocolitica. The first, and most straightforward,
would be to show that such isolates are found more
frequently among patients with gastroenteritis than
among healthy controls. The strains used in the
present study have necessitated culturing of about
13000 faecal samples in the participating laboratories,
and obtaining an equivalent number of control
specimens, mostly from children, is not considered
feasible. Only one study has used this approach so far,
and the authors reached a conclusion very similar to
ours [9]. A second approach to establish the patho-
genicity of biogroup 1A of Y. enterocolitica would be
the use of an animal model. However, present mouse
and rat models focus on systemic disease caused by
yersiniae, i.e. septicaemic infections and post-infec-
tious arthritis [24]. No simple animal models which
entirely reproduce human intestinal disease due to Y.
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enterocolitica have been described so far, even if the
role of the yst enterotoxin has been studied in rabbits
[25]. A third approach was therefore used in the
present study. The clinical syndromes associated with
Y. enterocolitica infections of strains belonging to
pathogenic biogroups were compared with symptoms
among patients, in whom a biogroup 1A of Y.
enterocolitica had been isolated from a faecal sample.
The reasoning was that the virulence attributes present
in pathogenic strains but absent from the biogroup 1A
isolates might affect the clinical course of illness. This
would allow some estimation of the contribution of
established virulence factors to the generation of
symptoms in intestinal yersiniosis in humans.
For this comparison to be valid, genetic methods
were used in addition to full biotyping in order to
ascertain that the patient strains included in the
comparison of clinical symptoms contained the full
set of known virulence attributes specific for patho-
genic Y. enterocolitica isolates. The correlation be-
tween biogroups and presence of ail as well as yst
genes was excellent in this set of fresh clinical isolates,
as expected on the basis of previous reports [26].
Interestingly, the only exceptional biogroup 1A isolate
hybridizing with the ail probe was associated with
symptoms of pseudoappendicitis in the patient from
whom it had been isolated. However, instead of the
expected 2-2 kb fragment, two Aval fragments of
10 kb and > 23 kb hybridized with the a//-probe on
Southern blots of this strain (results not shown).
Ribotypes also strongly correlated with biogroups of
Y. enterocolitica. The conserved profile of biogroup 4
reported here corresponds to the Neil ribotype II
found among European isolates described in a
previous report [27], and a closely related ribosomal
RNA profile was found among all pathogenic bio-
groups of yersiniae (Fig. 1).
No significant differences in clinical presentation
were found between the patient groups infected with
either pathogenic Y. enterocolitica biogroups or
strains of the non-pathogenic biogroup 1A. In a
previous report, significant differences in clinical
symptoms associated with Y. enterocolitica biogroups
had been found, but no information on virulence
traits were given in that paper [22]. The chromosomal
virulence genes ail and yst, as well as the virulence
plasmid, which are found exclusively among Y.
enterocolitica strains belonging to pathogenic bio-
groups, may fail to influence the clinical symptoms of
intestinal infection, and may be of more importance in
cases of disseminated disease. Some evidence has
already been presented to show that the invasion-
associated 7/7v gene, universally present in all Y.
enterocolitica isolates, may be critical in mediating
intestinal disease [28]. Thus, it is not too surprising to
find biogroup 1A isolates associated with disease, and
all our isolates have been shown to hybridize to an inv
probe (results not shown).
The gastrointestinal symptoms observed among the
study patients tended to be generally milder than in
other reports [29,30]. These relatively mild symptoms
may be explained by the fact that only 40% of
patients were below the age of 10 years, as age has
been shown to influence strongly the clinical pres-
entation of disease due to Y. enterocolitica of biogroup
4 [31]. However, the subjects included in the present
study represent the age range of patients likely to be
encountered in a sample of yersiniosis cases from the
general population [32]. The fact that all strains
reported on here were isolated by direct plating of a
faecal specimen further supports their clinical signifi-
cance.
No definite proof of the pathogenicity of all
biogroup 1A isolates can be based on the data
presented. However, there is evidence that some
biogroup 1A strains may be host-adapted and,
perhaps, pathogenic. Molecular evidence for the
occurrence of human-adapted biogroup 1A has been
reported before. Clear differences between environ-
mental and human isolates of biogroup 1A strains of
Y. enterocolitica had been shown by multilocus
enzyme electrophoresis [33]. The ribotyping results
presented here support this grouping. Environmental
Y. enterocolitica isolates from the study cited above
[33] showed 16S ribotypes clearly different from the
majority of patient strains (Fig. 1). Only one of the
patient isolates belonging to biogroup 1A showed a
profile resembling the environmental strains. The
ribosomal RNA profiles of the remaining patient
strains of biogroup 1A on the other hand, were
strongly conserved. This group of strains with related
multilocus enzyme electrophoresis patterns and simi-
lar ribotypes may represent a cluster of pathogenic
biogroup 1A isolates of Y. enterocolitica.
The limited clinical differences observed between
patients infected with biogroup 1A compared with
those infected with pathogenic biogroup isolates of Y.
enterocolitica, would suggest that clinical laboratories
could minimize resources needed for biogrouping.
The usefulness of different phenotypic tests for this
purpose has already been evaluated by several
investigators [26,34]. Some points seem worth empha-
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sizing. The discrimination between pathogenic and
non-pathogenic biogroups by sodium acetate utiliza-
tion has not been reported before. We also found the
detection of calcium dependence and congo-red
binding on CR-MOX medium [15] to be very reliable
for recognition of pathogenic yersiniae. This was due
to the fact that none of the strains analysed had lost
their virulence plasmids. In fact, we have never
observed plasmid loss in our collection of Yersinia
strains, even after repeated passages in vitro, if care
was taken not to use incubation temperatures above
30 °C. The poor specificity of slide agglutination for
detection of pathogenic yersiniae was due to the fact
that 27 % of the non-pathogenic isolates reacted in the
05 serum. For serogroups O3 and O9, there was an
excellent correlation between pathogenicity and slide
agglutination. It is known that O5, 27 is a het-
erogeneous serogroup [35], comprising both patho-
genic and non-pathogenic isolates. Therefore, except
for serogroups O3 and O9, the local distribution of
strains reacting in the O5 serum has to be ascertained
with other methods before relying on slide aggluti-
nation for pathogenicity determination. However,
none of the biochemical tests or sera mentioned above
are easily available from commercial sources. There-
fore, testing for aesculin hydrolysis on a commercial
bile aesculin agar has been found to be the most
convenient and inexpensive method for distinguishing
pathogenic (aesculin negative) from non-pathogenic
(aesculin positive) biogroups of Y. enterocolitica.
Accumulating biogrouping data from more patients
in different parts of the world may help to resolve
some of the questions raised by this report.
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